Retraction: Synergistic combination of violacein and azoles that leads to enhanced killing of major human pathogenic dermatophytic fungi Trichophyton rubrum [Front. Cell. Infect. Microbiol., 5, (2015), (57)] doi: 10.3389/fcimb.2015.00057;Synergistic combination of violacein and azoles that leads to enhanced killing of major human pathogenic dermatophytic fungi Trichophyton rubrum

Frontiers in Cellular and Infection Microbiology

Volumn 5, Issue AUG, 2015, Pages

  Anju, S ^a   Kumar, Nishanth S ^a   Krishnakumar, B ^a   Dileep Kumar, B S ^a  

^a REGIONAL RESEARCH LABORATORY CSIR   (India)

Author keywords

Azoles; Dermatophytosis; Synergistic; Trichophyton rubrum; Violacein

Indexed keywords

CLOTRIMAZOLE; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; PIGMENT; UNCLASSIFIED DRUG; VIOLACEIN; ANTIFUNGAL AGENT; INDOLE DERIVATIVE; PYRROLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; MTT ASSAY; MYCELIAL GROWTH; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SPECTROPHOTOMETRY; TRICHOPHYTON RUBRUM; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; FIBROBLAST; FUNGUS SPORE; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MYCELIUM; PHYSIOLOGY; TIME FACTOR; TRICHOPHYTON; ULTRASTRUCTURE;

ANTIFUNGAL AGENTS; AZOLES; CELL SURVIVAL; CELLS, CULTURED; DRUG SYNERGISM; FIBROBLASTS; HUMANS; INDOLES; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, SCANNING; MYCELIUM; SPORES, FUNGAL; TIME FACTORS; TRICHOPHYTON;

EID: 85006186614     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2017.00496     Document Type: Erratum

References (36)

1. Aala, F., Yusuf, U. K., Khodavandi, A., and Jamal, F. (2010). In vitro antifungal activity of allicin alone and in combination with two medications against six dermatophytic fungi. Afr. J. Microbiol. Res. 4, 380-385.
2. Almeida, S. R. (2008). Immunology of dermatophytosis. Mycopathologia 166, 277-283. doi: 10.1007/s11046-008-9103-6.
3. Anto, R. J., Venkataraman, M., and Karunagaran, D. (2003). Inhibition of NF-KB Sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistance. J. Biol. Chem. 28, 25490-25498. doi: 10.1074/jbc.M301790200.
4. Asticcioli, S., Di Silverio, A., Sacco, L., Fusi, I., Vincenti, L., and Romero, E. (2008). Dermatophyte infections in patients attending a tertiary care hospital in Northern Italy. New Microbiol. 31, 543-548.
5. Baltazar, L. M., Soares, B. M., Carneiro, H. C. S., Avila, T. V., Gouveia, L. F., Souza, D. G., et al. (2013). Cisalpino PS. Photodynamic inhibition of Trichophyton rubrum: in vitro activity and the role of oxidative and nitrosative bursts in fungal death. J. Antimicrob. Chemother. 68, 354-361. doi: 10.1093/jac/dks414.
6. Bitencourt, T. A., Komoto, T. T., Massaroto, B. G., Miranda, C. E. S., Beleboni, R. O., Marins, M., et al. (2013). Trans-chalcone and quercetin down-regulate fatty acid synthase gene expression and reduce ergosterol content in the human pathogenic dermatophyte Trichophyton rubrum. BMC Complement. Altern. Med. 13:229. doi: 10.1186/1472-6882-13-229.
7. Cazoto, L. L., Martins, D., Ribeiro, M. G., Durán, N., and Nakazato, G. (2011). Antibacterial activity of violacein against Staphylococcus aureus isolated from bovine mastitis. J. Antibiot. 64, 395-397. doi: 10.1038/ja.2011.13.
8. Chambers, H. F. (2006). "General principles of antimicrobial therapy," in Goodman and Gilman's Pharmacologiced Basis of Therapeutics, ed L. L. Bruton (New York, NY: McGraw-Hill), 1102-1104.
9. Chang, C. H., Young-Xu, Y., Kurth, T., Orav, J. E., and Chan, A. K. (2007). The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. Am. J. Med. 120, 791-798. doi: 10.1016/j.amjmed.2007.03.021.
10. CLSI. (2008). Clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, Approved Standard, CLSI document M38-A2, 2nd Edn. Wayne, Pa: CLSI.
11. Cronin, L., Moffitt, M., Mawad, D., Morton, O. C., Lauto, A., and Stack, C. (2014). An in vitro study of the photodynamic effect of rose Bengal on Trichophyton rubrum. J. Biophot. 7, 410-417. doi: 10.1002/jbio.201200168.
12. Endo, E. H., Cortez, D. A. G., Ueda-Nakamura, T., Nakamura, C. V., and Dias Filho, B. P. (2010). Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans. Res. Microbiol. 161, 534-540. doi: 10.1016/j.resmic.2010.05.002.
13. Ghannoum, M., Isham, N., Verma, A., Plaum, S., Fleischer, A., and Hardas, B. (2013). In vitro antifungal activity of naftifine hydrochloride against dermatophytes. Antimicrob. Agents Chemother. 57, 4369-4372. doi: 10.1128/AAC.01084-13.
14. Jin, J., Guo, N., Zhang, J., Ding, Y., Tang, X., Liang, J., et al. (2010). The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans. Lett. Appl. Microbiol. 51, 351-357 doi: 10.1111/j.1472-765X.2010.02900.x.
15. Khan, M. S. A., and Ahmad, I. (2011). Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum. Appl. Microbiol. Biotechnol. 90, 1083-1094. doi: 10.1007/s00253-011-3152-3.
16. Kumar, S. N., Nisha, G. V., Sudaresan, A., Sree Kumar, M. M., Lankalapalli, R. S., and Dileep Kumar, B. S. (2014). Activity and synergistic interaction of azole drugs and phenazines isolated from Pseudomonas aeruginosa against Candida species. Med. Mycol. 52, 480-488. doi: 10.1093/mmy/myu012.
17. Lewis, R. E., and Kontoyiannis, D. P. (2001). Rationale for combination antifungal therapy. Pharmacotherapy 21, 149-164. doi: 10.1592/phco.21.12.149S.34505.
18. Martinez-Rossi, N. M., Peres, N. T. A., and Rossi, A. (2008). Antifungal resistance mechanisms in dermatophytes. Mycopathologia 166, 369-383. doi: 10.1007/s11046-008-9110-7.
19. Michaelsen, A., Piñar, G., and Pinzari, F. (2010). Molecular and microscopical investigation of the microflora inhabiting a deteriorated italian manuscript dated from the thirteenth century. Microb. Ecol. 60, 69-80. doi: 10.1007/s00248-010-9667-9.
20. Mishra, B. B., and Tiwari, V. K. (2011). Natural products: an evolving role in future drug discovery. Eur. J. Med. Chem. 46, 4769-4807. doi: 10.1016/j.ejmech.2011.07.057.
21. Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., and Ghannoum, M. A. (2005). Combination treatment of invasive fungal infections. Clin. Microbiol. Rev. 18, 163-194. doi: 10.1128/CMR.18.1.163-194.2005.
22. Ohara, T., and Tsuge, T. (2004). FoSTUA, Encoding a basic helix-loop-helix protein, differentially regulates development of three kinds of asexual spores, macroconidia, microconidia, and chlamydoconidia, in the fungal plant pathogen Fusarium oxysporum. Eukaryotic Cell 3, 1412-1422. doi: 10.1128/EC.3.6.1412-1422.2004.
23. Park, S. T., Collingwood, A. M., St-Hilaire, S., and Sheridan, P. P. (2014). Inhibition of Batrachochytrium dendrobatidis caused by bacteria isolated from the skin of Boreal Toads, Anaxyrus (Bufo) boreas boreas, from Grand Teton National Park, Wyoming, USA. Microbiol. Insights 7, 1-8. doi: 10.4137/MBI.S13639.
24. Pereira, F. D. O., Mendes, J. M., and Lima, E. D. O. (2013). Investigation on mechanism of antifungal activity of eugenol against Trichophyton rubrum. Med. Mycol. 51, 507-513 doi: 10.3109/13693786.2012.742966.
25. Pereira, F. O., Mendes, J. M., Lima, I. O., Mota, K. S. L., Oliveira, W. A., and Lima, E. O. (2015). Antifungal activity of geraniol and citronellol, two monoterpenes alcohols, against Trichophyton rubrum involves inhibition of ergosterol biosynthesis. Pharm. Biol. 53, 228-234 doi: 10.3109/13880209.2014.913299.
26. Reuk-ngam, N., Chimnoi, N., Khunnawutmanotham, N., and Techasakul, S. (2014). Antimicrobial activity of coronarin D and its synergistic potential with antibiotics. BioMed. Res. Inter. 2014:581985. doi: 10.1155/2014/581985.
27. Seebacher, C., Bouchara, J. P., and Mignon, B. (2008). Updates on the epidemiology of dermatophyte infections. Mycopathologia 166, 335-352. doi: 10.1007/s11046-008-9100-9.
28. Soares, L. A., Gullo, F. P., Sardi, J. C. O., Pitangui, N. S., Costa-Orlandi, C. B., Sangalli-Leite, F., et al. (2014). Anti-Trichophyton activity of protocatechuates and their synergism with fluconazole. Evid. Based Complemen. Altern. Med. 14, 1-9. doi: 10.1155/2014/957860.
29. Subramaniam, S., Ravi, V., and Sivasubramanian, A. (2014). Synergistic antimicrobial profiling of violacein with commercial antibiotics against pathogenic micro-organisms. Pharm. Biol. 52, 86-90. doi: 10.3109/13880209.2013.815634.
30. Szepietowski, J. C., and Reich, A. (2009). Stigmatisation in onychomycosis patients: a population-based study. Mycoses 52, 343-349. doi: 10.1111/j.1439-0507.2008.01618.x.
31. Tchernev, G., Penev, P. K., Nenoff, P., Zisova, L. G., Cardoso, J. C., Taneva, T., et al. (2013). Onychomycosis: modern diagnostic and treatment approaches. Wien. Med. Wochenschr. 163, 1-12. doi: 10.1007/s10354-012-0139-3.
32. Uppuluri, P., Nett, J., Heitman, J., and Andes, D. (2008). Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob. Agents Chemother. 52, 1127-1132. doi: 10.1128/AAC.01397-07.
33. Van Minnebruggen, G., Francois, I. E. J. A., Cammue, B. P. A., Borgers, V., and Shroot, M. (2010). A general overview on past, present and future antimycotics. Open Mycol. J. 4, 22-32. doi: 10.2174/1874437001004010022.
34. Wang, H., Wang, F., Zhua, X., Yan, Y., Yua, X., Jiang, P., et al. (2012). Biosynthesis and characterization of violacein, deoxyviolacein and oxyviolacein in heterologous host, and their antimicrobial activities. Biochem. Eng. J. 67, 148-155. doi: 10.1016/j.bej.2012.06.005.
35. Warshaw, E. M. (2006). Evaluating costs for onychomycosis treatments: a practitioner's perspective. J. Am. Podiatr. Med. Assoc. 96, 38-52. doi: 10.7547/0960038.
36. Woodfolk, J. A. (2005). Allergy and dermatophytes. Clin. Microbiol. Rev. 18, 30-43. doi: 10.1128/CMR.18.1.30-43.2005.